Home - Products - Others - Other Targets - 2-(3,5-dibromo-4-methoxyphenyl)acetic acid

2-(3,5-dibromo-4-methoxyphenyl)acetic acid

CAS No. 89936-29-8

2-(3,5-dibromo-4-methoxyphenyl)acetic acid ( 3,5-dibromo-4-methoxy-phenylacetic acid; 3,5-Dibromo-4-methoxybenzeneacetic acid; )

Catalog No. M29510 CAS No. 89936-29-8

2-(3,5-dibromo-4-methoxyphenyl)acetic acid is a marine derived natural products found in Ianthella quadrangulata.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 264 Get Quote
5MG 403 Get Quote
10MG 592 Get Quote
25MG 888 Get Quote
50MG 1242 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    2-(3,5-dibromo-4-methoxyphenyl)acetic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    2-(3,5-dibromo-4-methoxyphenyl)acetic acid is a marine derived natural products found in Ianthella quadrangulata.
  • Description
    2-(3,5-dibromo-4-methoxyphenyl)acetic acid is a marine derived natural products found in Ianthella quadrangulata.
  • Synonyms
    3,5-dibromo-4-methoxy-phenylacetic acid; 3,5-Dibromo-4-methoxybenzeneacetic acid;
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    89936-29-8
  • Formula Weight
    324.0
  • Molecular Formula
    C9H8Br2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Dibenzosuberone

    Pharmaceutical intermediates for the synthesis of drug amitriptyline.

  • Caracemide

    Caracemide inhibits the enzyme ribonucleotide reductase of Escherichia coli. Caracemide can be used in anticancer studies.

  • Saikosaponin C

    Saikosaponin C efficiently inhibited LPS-induced apoptotic cell death via inhibition of caspase-3 activation and caspase-3-mediated-FAK degradation.